MindMaze Therapeutics Holding S.A. (RLFTF)
MindMaze Therapeutics Holding S.A. operates in the Biotechnology industry of the Healthcare sector, headquartered in Geneva, GE, CH. The stock last traded at $0.22, down 15.85% on the session, giving a market capitalisation of $2.8M. On trailing twelve-month figures it carries a trailing P/E of -0.38, a net margin of -1543.0%. Its beta of 1.23 implies it has historically moved more than the broad market.
MindMaze Therapeutics Holding SA engages in the development of AI-powered neurotherapeutics and pharmacological treatments for brain disorders. It focuses on addressing neurological and neuropsychiatric conditions through advanced research, clinical development, and technology-driven solutions. The company is headquartered in Geneva, Switzerland.
MindMaze Therapeutics Holding S.A. is most often compared with the following Healthcare names: